Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The person must be under 18 years of age at the time of joining the trial.
- The person must have one of two specific types of epilepsy: either a treatment-resistant focal epilepsy linked to a visible brain abnormality, or a rare type of epilepsy where no brain abnormality is visible on scans.
- The person must show abnormal brain activity patterns (called spikes) on an EEG (a test that measures electrical activity in the brain) taken between seizures.
- The person must have been reviewed and approved by a specialist team dedicated to epilepsy care.
- For those with treatment-resistant epilepsy linked to a visible brain abnormality, the person must already be scheduled to have a type of brain monitoring procedure using electrodes placed inside the skull (called SEEG) as part of their pre-surgical assessment.
- The person must be enrolled in a health insurance scheme.
Who may not be able to join:
- People who need general anesthesia to undergo an MRI scan.
- People who would require sedation specifically for the purposes of the research (rather than for their regular care).
- People who have a generalised form of epilepsy (where seizures affect the whole brain from the start, rather than beginning in one area).
- People who are under legal guardianship or are not free to make their own decisions (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 (0)1 44 49 51 75
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determine whether, in children with lesional focal epilepsy, the combination of ASL-MRI-EEG and resting-state fMRI-EEG can accurately identify the epileptogenic zone to be defined by SEEG, today's gold standard.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.